Kymera Therapeutics on Track for Record High Closing

Dow Jones
Aug 17

Kymera Therapeutics, Inc. (KYMR) is currently at $120.86, up $3.47 or 2.96%

 

--Would be new all-time closing high (Based on available data back to Aug. 21, 2020)

--On pace for largest percent increase since Aug. 12, 2026, when it rose 4.02%

--Currently up 10 consecutive days; up 20.49% over this period

--Longest winning streak since Jan. 3, 2022, when it rose for 11 straight trading days

--Best 10 day stretch since the 10 days ending July 6, 2026, when it rose 26.9%

--Up 16.89% month-to-date

--Up 55.33% year-to-date

--Up 177.07% from 52 weeks ago (Aug. 18, 2025), when it closed at $43.62

--Would be a new 52-week closing high

--Up 197.03% from its 52-week closing low of $40.69 on Sept. 2, 2025

--Traded as high as $120.86; highest intraday level since July 7, 2026, when it hit $120.90

--Up 2.96% at today's intraday high

 

All data as of 11:12:04 AM ET

 

Source: Dow Jones Market Data, FactSet

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10